C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2001
10/30/2001	US6309866 6-phosphogluconate dehydrogenase
10/30/2001	US6309864 Generation of human serum albumin; culture genetically engineerred cells, recover serum albumin
10/30/2001	US6309863 Immunizing an animal with the synthetic polypeptide which isa mimetic of the particular amino acid and is phosphorylated, collecting serum or ascitic fluid from immunized animal, screening for presence of antibodies specific for polypeptide
10/30/2001	US6309862 Methionine containing animal cell culture medium and its use
10/30/2001	US6309861 Process for the production of naturally folded and secreted proteins
10/30/2001	US6309856 Human MAD proteins and uses thereof
10/30/2001	US6309851 Generating genetically engineered polypeptide; transform cells, culture cells, recover genetically engineered polypeptide
10/30/2001	US6309846 Evaluating humans with cancer; perform immunoassays over time to determine adjustment in preferential antigen concentration, ajustment in antigen concentration indicates adjustment in cancer classification
10/30/2001	US6309841 Expression vector for the generation of stable genetically engineered polypeptides
10/30/2001	US6309834 Detecting homogeneity in nucleotide sequences; generate clones in cells, generate ribonucleic acids, amplify and resolve nucleotide sequences, clone preferential sequences into plasmid, determine sequence of preferential clones
10/30/2001	US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host.
10/30/2001	US6309645 A method of suppressing an immune response in a mammal.
10/30/2001	US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens.
10/30/2001	US6309641 Which can be used immunologically as a vaccine for leptospirosis caused by this organism.
10/30/2001	US6309638 Netrins
10/30/2001	US6309637 For treating or preventing disorders associated with expression of mag4v.
10/30/2001	CA2170143C Cell death regulator
10/30/2001	CA2093643C Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
10/30/2001	CA2047843C Method and product for the treatment of gastric disease
10/30/2001	CA2032153C Application of new dna fragments as sequence coding for a signal peptide for the secretion of mature proteins by recombinant yeasts, expression cassettes, processed yeasts and corresponding protein preparation process.
10/30/2001	CA2002833C Interferon-gamma binding proteins
10/25/2001	WO2001079558A1 High-throughput screening of expressed dna libraries in filamentous fungi
10/25/2001	WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	WO2001079494A1 Agonist antibodies
10/25/2001	WO2001079493A1 New lipid binding protein 2
10/25/2001	WO2001079492A2 Lipid binding protein 3
10/25/2001	WO2001079474A1 Method for modification of proteins by transglutaminase
10/25/2001	WO2001079468A2 Drug metabolizing enzymes
10/25/2001	WO2001079465A2 Nucleic acids encoding polypeptides having haloperoxidase activity
10/25/2001	WO2001079459A2 Polypeptides having haloperoxidase activity
10/25/2001	WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001	WO2001079291A2 Secreted proteins
10/25/2001	WO2001079289A2 Human interferon, zinf2
10/25/2001	WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001	WO2001079282A2 Molecules associated with human reproduction
10/25/2001	WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	WO2001079269A2 Lipid binding protein 4
10/25/2001	WO2001079266A1 Antibody against human kgfr
10/25/2001	WO2001079265A1 Antibody against human kgf
10/25/2001	WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	WO2001078756A2 Agent for postoperative use after the removal of bone tumours
10/25/2001	WO2001078503A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001	WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
10/25/2001	WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001	WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
10/25/2001	WO2000068249A3 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
10/25/2001	WO2000043492A9 Method of site specific labeling of proteins and uses therefor
10/25/2001	WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001	US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001	US20010034334 Genetic engineered polypeptide
10/25/2001	US20010034050 Fusion peptides isolatable by phase transition
10/25/2001	US20010034043 Useful as a host cell for expression of recombinant DNA sequences; expression of homologous and heterologous genes in F. heparinum and the coupling of expression to secretion of biologically active polypeptides or protein
10/25/2001	US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001	US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
10/25/2001	US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein
10/25/2001	US20010033878 Reducing the oxygen content in a food and feed product to improve shelf life and quality, or producing metabolites
10/25/2001	DE10020125A1 Agent for stimulating bone regrowth, useful as insert after surgery for bone cancer, comprises single sequence expressing a fusion of growth factor and protease inhibitor
10/25/2001	CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	CA2406590A1 Agent for postoperative use after the removal of bone tumours
10/25/2001	CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	CA2406195A1 Lipid binding protein 4
10/25/2001	CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001	CA2406087A1 New lipid binding protein 2
10/25/2001	CA2406066A1 Lipid binding protein 3
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/25/2001	CA2376552A1 High-throughput screening of expressed dna libraries in filamentous fungi
10/24/2001	EP1148339A2 Immunoassay for LSD and 2-Oxo-3-Hydroxy-LSD
10/24/2001	EP1148125A1 Human nucleoprotein having www domain and polynucleotide encoding the same
10/24/2001	EP1147415A1 Method and kit for extracting prion protein
10/24/2001	EP1147213A2 Novel rgs-containing molecules and uses thereof
10/24/2001	EP1147212A1 T helper cell epitopes
10/24/2001	EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
10/24/2001	EP1147196A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
10/24/2001	EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001	EP1147190A1 Her-2/neu fusion proteins
10/24/2001	EP1147187A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent
10/24/2001	EP1147178A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
10/24/2001	EP1147137A1 Methods for generating phosphorylation site-specific immunological reagents
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
10/24/2001	EP1147123A2 Novel odorant receptors in drosophila
10/24/2001	EP1146889A2 Identification of specific differentially expressed mycobacterial antigens
10/24/2001	EP0910405B1 Vaccine containing caprine arthritis-encephalitis virus and use for immunoprotection against hiv-1 infection
10/24/2001	EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
10/24/2001	EP0801686B1 Process for preparing cyclosporin a
10/24/2001	EP0801682B1 Process for the production of proteins
10/24/2001	EP0736099B1 Expression of self-processing polyproteins in transgenic plants
10/24/2001	EP0731709B1 Neutrophil inhibitors from nematodes
10/24/2001	CN1319140A Recombinant CELO virus and CELO virus DNA
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases

1 ... 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 ... 1125